The LEADER cardiovascular outcomes trial (N=9,340) demonstrated cardiovascular safety and a reduction in major adverse cardiovascular events with liraglutide 1.8 mg in patients with type 2 diabetes [9]
It can be found in many animal products and byproducts, such as dairy, beef, dark meat poultry, and shellfish (36)
Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, Diaz G, Tunstead J, Logothetis DE, Hajjar RJ, Schecter AD
Stroke is a leading cause of disability and the fifth leading cause of death in the U.S
It is distinct from Rybelsus (lower-dose oral semaglutide for type 2 diabetes) and, following MHRA approval in June 2026, is rolling out on private prescription during the second half of 2026 rather than on the NHS